Paper40237201
Downregulation of O-GlcNAcylation enhances etoposide-induced p53-mediated apoptosis in HepG2 human liver cancer cells.
Lee J and 5 others. FEBS Open Bio, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Downregulation of O-GlcNAcylation enhances etoposide-induced p53-mediated apoptosis in HepG2 human liver cancer cells. Papers, record 40237201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40237201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Downregulation of O-GlcNAcylation enhances etoposide-induced p53-mediated apoptosis in HepG2 human liver cancer cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Etoposide | Major topic |
| Apoptosis | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Liver Neoplasms | Major topic |
| Humans | |
| Hep G2 Cells | |
| N-Acetylglucosaminyltransferases | |
| Down-Regulation | |
| Cell Survival |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R&D Headquarters of Korea Ginseng Corporation | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22275356 | Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22275356 | PubMed |
| 2 | 20676906 | The dynamic stress-induced "O-GlcNAc-ome" highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways. | Amino Acids | 2011 | https://conductscience.org/library/papers/20676906 | PubMed |
| 3 | 12615051 | O-GlcNAc: a regulatory post-translational modification. | Biochem Biophys Res Commun | 2003 | https://conductscience.org/library/papers/12615051 | PubMed |
| 4 | 30793308 | Resistance to bortezomib in breast cancer cells that downregulate Bim through FOXA1 O-GlcNAcylation. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30793308 | PubMed |
| 5 | 17894897 | Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines. | Mol Cancer | 2007 | https://conductscience.org/library/papers/17894897 | PubMed |
| 6 | 18366759 | Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity. | Mol Cancer | 2008 | https://conductscience.org/library/papers/18366759 | PubMed |
| 7 | 30626734 | Nutrient regulation of signaling and transcription. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30626734 | PubMed |
| 8 | 30576620 | Tumor cell escape from therapy-induced senescence. | Biochem Pharmacol | 2019 | https://conductscience.org/library/papers/30576620 | PubMed |
| 9 | 20940128 | p53 at a glance. | J Cell Sci | 2010 | https://conductscience.org/library/papers/20940128 | PubMed |
| 10 | 35817809 | Protein O-GlcNAcylation in cardiovascular diseases. | Acta Pharmacol Sin | 2023 | https://conductscience.org/library/papers/35817809 | PubMed |
| 11 | 16598783 | Post-translational modification by O-GlcNAc: another way to change protein function. | J Cell Biochem | 2006 | https://conductscience.org/library/papers/16598783 | PubMed |
| 12 | 32851890 | Investigating the Impact of OGT Inhibition on Doxorubicin- and Docetaxel-Induced Cytotoxicity in PC-3 and WPMY-1 Cells. | Int J Toxicol | 2020 | https://conductscience.org/library/papers/32851890 | PubMed |
| 13 | 27343361 | O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling. | J Mol Biol | 2016 | https://conductscience.org/library/papers/27343361 | PubMed |
| 14 | 26600742 | Molecular mechanisms of etoposide. | EXCLI J | 2015 | https://conductscience.org/library/papers/26600742 | PubMed |
| 15 | 34943826 | Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells. | Cells | 2021 | https://conductscience.org/library/papers/34943826 | PubMed |
| 16 | 30824861 | The multiple mechanisms that regulate p53 activity and cell fate. | Nat Rev Mol Cell Biol | 2019 | https://conductscience.org/library/papers/30824861 | PubMed |
| 17 | 19377505 | DNA topoisomerase II and its growing repertoire of biological functions. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19377505 | PubMed |
| 18 | 23914174 | Mechanisms regulating resistance to inhibitors of topoisomerase II. | Front Pharmacol | 2013 | https://conductscience.org/library/papers/23914174 | PubMed |
| 19 | 33121131 | O-GlcNAc Transferase Inhibitor Synergistically Enhances Doxorubicin-Induced Apoptosis in HepG2 Cells. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33121131 | PubMed |
| 20 | 36768465 | Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768465 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41939458 | Regulation of glycosylation in radiotherapy: exploring the multiple effects of DNA damage, immune response, stromal microenvironment and metabolism. | Front Oncol | 2026 | https://conductscience.org/library/papers/41939458 | PubMed |
| 41466540 | Dammarenediol II enhances etoposide-induced apoptosis by targeting O-GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer. | Mol Oncol | 2026 | https://conductscience.org/library/papers/41466540 | PubMed |
| 41394960 | Protein O-GlcNAcylation in Health and Diseases. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41394960 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| OGT | 8473 | PubTator's text mining | https://conductscience.org/library/genes/8473 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| TOP2A | 7153 | PubTator's text mining | https://conductscience.org/library/genes/7153 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40237201
GET https://conductscience.org/api/papers/v1/40237201/references?page=2